Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M868Revenue $M277Net Margin (%)-11.3Altman Z-Score11.7
Enterprise Value $M749EPS $-1.0Operating Margin %-13.5Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.3Pre-tax Margin (%)-13.6Higher ROA y-yN
Price/Book5.810-y EBITDA Growth Rate %--Quick Ratio4.2Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %--Current Ratio4.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-16.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-21.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M32.5ROIC % (ttm)-86.8Gross Margin Increase y-yN

Gurus Latest Trades with GHDX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GHDXDavid Swensen 2013-03-31 Sold Out -2.8%$26.72 - $29.65
($28.5)
$ 26.73-6%Sold Out0
GHDXDavid Swensen 2012-12-31 Buy 2.8%$26.42 - $36.8
($30.13)
$ 26.73-11%New holding37,861
GHDXDavid Swensen 2011-03-31 Sold Out -0.93%$21.08 - $26.18
($23.29)
$ 26.7315%Sold Out0
GHDXDavid Swensen 2010-12-31 Buy 0.93%$13.18 - $23.52
($17.74)
$ 26.7351%New holding38,243
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GHDX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


GHDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Cole G BradleyCOO 2015-07-07Sell4,000$27.53-2.91 view
Cole G BradleyCOO 2015-06-09Sell4,000$26.241.87 view
Cole G BradleyCOO 2015-05-12Sell4,000$27.54-2.94 view
Popovits Kimberly JPresident and CEO 2015-04-13Sell3,000$31.28-14.55 view
Cole G BradleyCOO 2015-04-07Sell4,000$30.44-12.19 view
Popovits Kimberly JPresident and CEO 2015-03-12Sell3,000$31.91-16.23 view
Cole G BradleyCOO 2015-03-10Sell4,000$31.84-16.05 view
Popovits Kimberly JPresident and CEO 2015-02-12Sell3,000$29.86-10.48 view
Cole G BradleyCOO 2015-02-10Sell4,000$31.37-14.79 view
LIVINGSTON RANDALL SDirector 2015-02-02Sell1,000$31.93-16.29 view

Quarterly/Annual Reports about GHDX:

    News about GHDX:

    Articles On GuruFocus.com
    CEO of InVitae Corporation of Genomic Health Inc. Randal W. Scott Sold 30,000 Shares Jul 13 2012 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Mar 16 2011 
    Genomic Health Inc. (GHDX) CFO Dean L Schorno sells 1,000 Shares Mar 16 2011 
    Genomic Health Inc. (GHDX) Executive Chairman Randal W Scott sells 20,000 Shares Mar 14 2011 
    Genomic Health Inc. (GHDX) COO G Bradley Cole sells 2,500 Shares Mar 10 2011 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Feb 16 2011 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Feb 16 2011 
    Genomic Health Inc. (GHDX) CFO Dean L Schorno sells 1,000 Shares Feb 16 2011 
    Genomic Health Inc. (GHDX) Executive Chairman Randal W Scott sells 20,000 Shares Feb 14 2011 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Jan 19 2011 

    More From Other Websites
    Genomic Health, Inc. Q2 Earnings, 2015 Aug 25 2015
    Breast Cancer Research and Treatment Publishes Oncotype DX(R) DCIS Score(TM) Study Conducted in... Aug 20 2015
    Breast Cancer Research and Treatment Publishes Oncotype DX(R) DCIS Score(TM) Study Conducted in... Aug 20 2015
    Breast Cancer Research and Treatment Publishes Oncotype DX(R) DCIS Score(TM) Study Conducted in... Aug 20 2015
    Genomic Health Prostate Cancer Test Wins Medicare Coverage Aug 18 2015
    GENOMIC HEALTH INC Financials Aug 18 2015
    Genomic Health's Oncotype DX® Prostate Cancer Test Receives Medicare Coverage Aug 17 2015
    Genomic Health's Oncotype DX® Prostate Cancer Test Receives Medicare Coverage Aug 17 2015
    10-Q for Genomic Health, Inc. Aug 08 2015
    GENOMIC HEALTH INC Files SEC form 10-Q, Quarterly Report Aug 06 2015
    Genomic Health Q2 Loss Wider than Expected; Tests Ramp Up - Analyst Blog Aug 06 2015
    Edited Transcript of GHDX earnings conference call or presentation 4-Aug-15 8:30pm GMT Aug 04 2015
    Genomic Health reports 2Q loss Aug 04 2015
    Genomic Health reports 2Q loss Aug 04 2015
    Genomic Health Inc Earnings Call scheduled for 4:30 pm ET today Aug 04 2015
    GENOMIC HEALTH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 04 2015
    Genomic Health Announces Second Quarter 2015 Financial Results and Reports Record International and... Aug 04 2015
    Genomic Health Announces Second Quarter 2015 Financial Results and Reports Record International and... Aug 04 2015
    Q2 2015 Genomic Health Inc Earnings Release - After Market Close Aug 04 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK